Evidence map›Paper›PMID 27271051›Full record

ReviewEuropean journal of nuclear medicine and molecular imaging2017

Characterization of PET/CT images using texture analysis: the past, the present… any future?

Mathieu Hatt, Florent Tixier, Larry Pierce, Paul E Kinahan, Catherine Cheze Le Rest, Dimitris Visvikis

Abstract readReview
In one paragraph

Review in European journal of nuclear medicine and molecular imaging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 246 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
246citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

246 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Prognostic value of SPECT myocardial perfusion entropy in high-risk type 2 diabetic patients.European journal of nuclear medicine and molecular imaging · 2021
    Trial
  4. Trial
  5. Trial
  6. Review
  7. Development of aAnnals of nuclear medicine · 2026
    Article
  8. Observational
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Frontiers in immunology · 2026
    Article
  15. Article
  16. Article
  17. Nuclear medicine and molecular imaging · 2025
    Article
  18. Article
  19. Article
  20. Article

186 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mathieu HattINSERM, UMR 1101, LaTIM, University of Brest IBSAM, Brest, France. hatt@univ-brest.fr.
Florent TixierNuclear Medicine, University Hospital, Poitiers, France.
Larry PierceImaging Research Laboratory, University of Washington, Seattle, WA, USA.
Paul E KinahanImaging Research Laboratory, University of Washington, Seattle, WA, USA.
Catherine Cheze Le RestNuclear Medicine, University Hospital, Poitiers, France.
Dimitris VisvikisINSERM, UMR 1101, LaTIM, University of Brest IBSAM, Brest, France.

Funding

Advanced PET/CT Imaging for Improving Clinical TrialsU01CA148131 · NCI · UNIVERSITY OF WASHINGTON · PI KINAHAN, PAUL E., LINDEN, HANNAH M · 2010 to 2019
$6.0M
NCI NIH HHS U01 CA148131
6 · The paper itself

Abstract

After seminal papers over the period 2009 - 2011, the use of texture analysis of PET/CT images for quantification of intratumour uptake heterogeneity has received increasing attention in the last 4 years. Results are difficult to compare due to the heterogeneity of studies and lack of standardization. There are also numerous challenges to address. In this review we provide critical insights into the recent development of texture analysis for quantifying the heterogeneity in PET/CT images, identify issues and challenges, and offer recommendations for the use of texture analysis in clinical research. Numerous potentially confounding issues have been identified, related to the complex workflow for the calculation of textural features, and the dependency of features on various factors such as acquisition, image reconstruction, preprocessing, functional volume segmentation, and methods of establishing and quantifying correspondences with genomic and clinical metrics of interest. A lack of understanding of what the features may represent in terms of the underlying pathophysiological processes and the variability of technical implementation practices makes comparing results in the literature challenging, if not impossible. Since progress as a field requires pooling results, there is an urgent need for standardization and recommendations/guidelines to enable the field to move forward. We provide a list of correct formulae for usual features and recommendations regarding implementation. Studies on larger cohorts with robust statistical analysis and machine learning approaches are promising directions to evaluate the potential of this approach.

Indexed as

ForecastingAnimalsEvidence-Based MedicineHumansImage EnhancementImaging, Three-DimensionalPositron Emission Tomography Computed TomographyCritical reviewHeterogeneityImage texturePET/CTRecommendations

Identifiers

PMID27271051
PMCPMC5283691

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.